ZD-4190
Catalog No. A22369
ZD-4190 is a potent, orally available inhibitor of the vascular endothelial cell growth factor receptor 2 (VEGFR2) and of epidermal growth factor receptor (EGFR) signalling, used for the treatment of cancer.
| Catalog Num | A22369 |
|---|---|
| M. Wt | 459.27 |
| Formula | C19H16BrFN6O2 |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 413599-62-9 |
| Synonyms | ZD4190,ZD 4190 |
| SMILES | COC1=CC2=C(NC3=CC=C(Br)C=C3F)N=CN=C2C=C1OCCN4N=NC=C4 |
ZD-4190 is a potent, orally available inhibitor of the vascular endothelial cell growth factor receptor 2 (VEGFR2) and of epidermal growth factor receptor (EGFR) signalling, used for the treatment of cancer.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 21.77 mL | 108.87 mL | 217.74 mL |
| 0.5 mM | 4.35 mL | 21.77 mL | 43.55 mL |
| 1 mM | 2.18 mL | 10.89 mL | 21.77 mL |
| 5 mM | 0.44 mL | 2.18 mL | 4.35 mL |
*The above data is based on the productmolecular weight 459.27. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
ADOOQ 产品质量保证
We promise all products to perform as described.